CN105087468A - Method for effectively inducing stem cells to differentiate into pancreas islet beta cells - Google Patents
Method for effectively inducing stem cells to differentiate into pancreas islet beta cells Download PDFInfo
- Publication number
- CN105087468A CN105087468A CN201510553190.4A CN201510553190A CN105087468A CN 105087468 A CN105087468 A CN 105087468A CN 201510553190 A CN201510553190 A CN 201510553190A CN 105087468 A CN105087468 A CN 105087468A
- Authority
- CN
- China
- Prior art keywords
- cell
- islet beta
- cytodifferentiation
- hours
- induced dry
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 33
- 210000000130 stem cell Anatomy 0.000 title claims abstract description 30
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 title abstract description 7
- 230000001939 inductive effect Effects 0.000 title abstract description 5
- 210000000496 pancreas Anatomy 0.000 title abstract 3
- 210000004027 cell Anatomy 0.000 claims abstract description 36
- 239000000556 agonist Substances 0.000 claims abstract description 10
- 230000002776 aggregation Effects 0.000 claims abstract description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 13
- 244000309466 calf Species 0.000 claims description 12
- 239000002609 medium Substances 0.000 claims description 12
- 210000002966 serum Anatomy 0.000 claims description 12
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 7
- 210000004369 blood Anatomy 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 6
- 206010012601 diabetes mellitus Diseases 0.000 claims description 6
- 238000002347 injection Methods 0.000 claims description 6
- 239000007924 injection Substances 0.000 claims description 6
- 108010010803 Gelatin Proteins 0.000 claims description 5
- 210000004700 fetal blood Anatomy 0.000 claims description 5
- 229920000159 gelatin Polymers 0.000 claims description 5
- 239000008273 gelatin Substances 0.000 claims description 5
- 235000019322 gelatine Nutrition 0.000 claims description 5
- 235000011852 gelatine desserts Nutrition 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 238000004114 suspension culture Methods 0.000 claims description 5
- 238000002965 ELISA Methods 0.000 claims description 4
- 230000006698 induction Effects 0.000 claims description 4
- 238000004220 aggregation Methods 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 230000001900 immune effect Effects 0.000 claims description 3
- 210000004185 liver Anatomy 0.000 claims description 3
- MFBOGIVSZKQAPD-UHFFFAOYSA-M sodium butyrate Chemical compound [Na+].CCCC([O-])=O MFBOGIVSZKQAPD-UHFFFAOYSA-M 0.000 claims description 3
- 108010023082 activin A Proteins 0.000 claims description 2
- 230000000975 bioactive effect Effects 0.000 claims description 2
- 210000001671 embryonic stem cell Anatomy 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 210000003954 umbilical cord Anatomy 0.000 claims description 2
- 230000004069 differentiation Effects 0.000 abstract description 13
- 201000001421 hyperglycemia Diseases 0.000 abstract description 6
- 102000004877 Insulin Human genes 0.000 abstract description 4
- 108090001061 Insulin Proteins 0.000 abstract description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract description 4
- 230000007423 decrease Effects 0.000 abstract description 2
- 229940125396 insulin Drugs 0.000 abstract description 2
- 238000005054 agglomeration Methods 0.000 abstract 1
- 230000003914 insulin secretion Effects 0.000 abstract 1
- 210000002955 secretory cell Anatomy 0.000 abstract 1
- VOUAQYXWVJDEQY-QENPJCQMSA-N 33017-11-7 Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 VOUAQYXWVJDEQY-QENPJCQMSA-N 0.000 description 3
- 108010075254 C-Peptide Proteins 0.000 description 3
- 230000006378 damage Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000010172 mouse model Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 101150105382 MET gene Proteins 0.000 description 1
- 208000016285 Movement disease Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000006470 autoimmune attack Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 238000003209 gene knockout Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000002660 insulin-secreting cell Anatomy 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000003716 mesoderm Anatomy 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000012207 quantitative assay Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000009256 replacement therapy Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000009168 stem cell therapy Methods 0.000 description 1
- 238000009580 stem-cell therapy Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510553190.4A CN105087468B (en) | 2015-09-01 | 2015-09-01 | A kind of method of efficient induction stem cell to pancreatic islet beta sample cell differentiation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510553190.4A CN105087468B (en) | 2015-09-01 | 2015-09-01 | A kind of method of efficient induction stem cell to pancreatic islet beta sample cell differentiation |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105087468A true CN105087468A (en) | 2015-11-25 |
CN105087468B CN105087468B (en) | 2018-12-07 |
Family
ID=54568804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510553190.4A Active CN105087468B (en) | 2015-09-01 | 2015-09-01 | A kind of method of efficient induction stem cell to pancreatic islet beta sample cell differentiation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105087468B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109053866A (en) * | 2018-09-03 | 2018-12-21 | 洛阳轩智生物科技有限公司 | The improved method that epidermal stem cells break up to pancreatic cell |
US20210024639A1 (en) * | 2018-01-03 | 2021-01-28 | Agomab Therapeutics | Methods for promoting pancreatic islet cell growth |
CN113544259A (en) * | 2020-01-31 | 2021-10-22 | 瑞帝安有限公司 | Method for differentiating human adipose-derived mesenchymal stem cells into hair papilla cells |
US12084504B2 (en) | 2016-06-27 | 2024-09-10 | Agomab Therapeutics | Anti-MET antibodies and uses thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1298201A1 (en) * | 2001-09-27 | 2003-04-02 | Cardion AG | Process for the production of cells exhibiting an islet-beta-cell-like state |
CN101160390A (en) * | 2005-04-15 | 2008-04-09 | 北京大学 | Method of inducing embryonic stem cells into pancreatic cells |
CN101603027A (en) * | 2008-06-12 | 2009-12-16 | 西北农林科技大学 | Method for inducing human bone marrow mesenchymal stem cells to differentiate into islet-like cells in vitro |
-
2015
- 2015-09-01 CN CN201510553190.4A patent/CN105087468B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1298201A1 (en) * | 2001-09-27 | 2003-04-02 | Cardion AG | Process for the production of cells exhibiting an islet-beta-cell-like state |
CN101160390A (en) * | 2005-04-15 | 2008-04-09 | 北京大学 | Method of inducing embryonic stem cells into pancreatic cells |
CN101603027A (en) * | 2008-06-12 | 2009-12-16 | 西北农林科技大学 | Method for inducing human bone marrow mesenchymal stem cells to differentiate into islet-like cells in vitro |
Non-Patent Citations (3)
Title |
---|
《自然科学进展》 * |
李艳华等: "成人骨髓间充质干细胞体外定向诱导分化为胰岛样细胞团的研究", 《自然科学进展》 * |
王波等: "胚胎干细胞向胰岛细胞诱导分化的研究", 《国外医学生物医学工程分册》 * |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US12084504B2 (en) | 2016-06-27 | 2024-09-10 | Agomab Therapeutics | Anti-MET antibodies and uses thereof |
US20210024639A1 (en) * | 2018-01-03 | 2021-01-28 | Agomab Therapeutics | Methods for promoting pancreatic islet cell growth |
CN109053866B (en) * | 2018-09-03 | 2020-12-15 | 北京中京高科生物科技有限公司 | Improved method for differentiation of epidermal stem cells into pancreatic cells |
CN111848745A (en) * | 2018-09-03 | 2020-10-30 | 洛阳轩智生物科技有限公司 | Improved method for differentiation of epidermal stem cells into pancreatic cells |
CN111875674A (en) * | 2018-09-03 | 2020-11-03 | 洛阳轩智生物科技有限公司 | Improved method for differentiation of epidermal stem cells into pancreatic cells |
CN111875675A (en) * | 2018-09-03 | 2020-11-03 | 洛阳轩智生物科技有限公司 | Improved method for differentiation of epidermal stem cells into pancreatic cells |
CN109053866A (en) * | 2018-09-03 | 2018-12-21 | 洛阳轩智生物科技有限公司 | The improved method that epidermal stem cells break up to pancreatic cell |
CN111848743A (en) * | 2018-09-03 | 2020-10-30 | 洛阳轩智生物科技有限公司 | Improved method for differentiation of epidermal stem cells into pancreatic cells |
CN111848744B (en) * | 2018-09-03 | 2021-07-23 | 宁波希诺赛生物科技有限公司 | Improved method for differentiation of epidermal stem cells into pancreatic cells |
CN111875674B (en) * | 2018-09-03 | 2021-12-10 | 内蒙古创润生物科技有限公司 | Improved method for differentiation of epidermal stem cells into pancreatic cells |
CN111848745B (en) * | 2018-09-03 | 2022-01-18 | 山东卓东生物科技有限公司 | Improved method for differentiation of epidermal stem cells into pancreatic cells |
CN111848744A (en) * | 2018-09-03 | 2020-10-30 | 洛阳轩智生物科技有限公司 | Improved method for differentiation of epidermal stem cells into pancreatic cells |
CN113544259A (en) * | 2020-01-31 | 2021-10-22 | 瑞帝安有限公司 | Method for differentiating human adipose-derived mesenchymal stem cells into hair papilla cells |
Also Published As
Publication number | Publication date |
---|---|
CN105087468B (en) | 2018-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2351648C2 (en) | Adipose stromal cell differentiation into endocrine pancreas cells and application thereof | |
CN105087468A (en) | Method for effectively inducing stem cells to differentiate into pancreas islet beta cells | |
KR101885122B1 (en) | Spheroidal culture method of tonsil-derived mesenchymal stem cells for accelerating differentiation efficacy and maintenance of stemness | |
Tapia et al. | Biology and pathological implications of brown adipose tissue: promises and caveats for the control of obesity and its associated complications | |
Nemati et al. | Efficiency of stem cell (SC) differentiation into insulin‐producing cells for treating diabetes: a systematic review | |
JP2024023760A (en) | Mesenchymal stem cell and therapeutic agent for neuropathy | |
JP2024105510A (en) | Compositions and methods for expanding insulin-producing pancreatic islet cells and their therapeutic uses | |
EP0190337A1 (en) | A process for proliferation of wholly or partially differentiated beta-cellls | |
JP5268009B2 (en) | Methods for establishing and differentiating adult pancreatic stem cells | |
Zhoujun et al. | Transplantation of insulin‐producing cells derived from human MSCs to treat diabetes in a non‐human primate model | |
JP6453753B2 (en) | Adipose tissue cell | |
JP6994729B1 (en) | A therapeutic agent for osteoarthritis or ligaments or tendons, and a method for producing the same. | |
KR102148425B1 (en) | Composition for inducing differentiation into insulin producing cells and uses thereof | |
Pittenger et al. | A role for islet neogenesis in curing diabetes | |
JP5294041B2 (en) | Pancreatic cell regenerative transplant kit for pancreatic disease or diabetes | |
Won et al. | Glucose-responsive gene expression system for gene therapy | |
Câmara et al. | Differentiation of mesenchymal stem cells from humans and animals into insulin-producing cells: an overview in vitro induction forms | |
Will et al. | Stem cell therapy to restore pancreatic function in dogs and cats. | |
KR101998633B1 (en) | Use of ellipticine for inducing differentiation of stem cells into chondrocytes | |
KR102513507B1 (en) | Prevention or treatment of organ fibrosis | |
Ochyra et al. | The use of stem cells in the treatment of diabetes mellitus and its complications-review | |
Chernysheva et al. | Development, regeneration, and physiological expansion of functional β-cells: Cellular sources and regulators | |
Qin et al. | Pancreatic stellate cells support human pancreatic β-cell viability in vitro and enhance survival of immunoisolated human islets exposed to cytokines | |
Balahmar | Differentiation of Stem Cells into Pancreatic Lineage: In vitro Cell Culture, in vivo Transplantation in Animal Models | |
CA3231258A1 (en) | Compositions and methods for propogating insulin and glucagon secreting cells from type 1 diabetic pancreatic tissue and therapeutic uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Shanghai Golden Medical Insurance Bioengineering Co.,Ltd. Document name: Notification that Application Deemed not to be Proposed |
|
TR01 | Transfer of patent right |
Effective date of registration: 20200605 Address after: 201500 room 214 215, No.254, South trade road, Zhujing Town, Jinshan District, Shanghai Patentee after: Shanghai Golden Medical Insurance Bioengineering Co.,Ltd. Address before: Four pailou Nanjing Xuanwu District of Jiangsu Province, No. 2 211189 Patentee before: SOUTHEAST University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230418 Address after: Room 403, No. 6, Lane 220, Sida Road, Hongkou District, Shanghai, 200081 Patentee after: Xia Liang Address before: Room 214 215, No. 254 Trade South Road, Zhujing Town, Jinshan District, Shanghai, 201500 Patentee before: Shanghai Golden Medical Insurance Bioengineering Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231130 Address after: Room J, 12th Floor, Building 1, No. 399, Zhongren Road, Jiading District, Shanghai, 200000 Patentee after: Shanghai Junze Leen Biotechnology Co.,Ltd. Address before: Room 403, No. 6, Lane 220, Sida Road, Hongkou District, Shanghai, 200081 Patentee before: Xia Liang |
|
TR01 | Transfer of patent right |